Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.36 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.35 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.35 |
| ▸ | ITGB7 | P26010 | 2/20 | 0.35 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1747950 | 0.83 | CD274 (0.42) | L3MBTL1CYP3A4CYP2C9PKMCYP2C19 | |
| SCHEMBL1747957 | 0.72 | POLB (0.42) | CYP3A4 | |
| SCHEMBL1854430 | 0.70 | SLC6A3 (0.71) | SLC6A3SLC6A4ALDH1A1SLC6A2CYP2C9 | |
| SCHEMBL28693105 | 0.70 | BCAT2 (0.46) | SLC6A3SLC6A4L3MBTL1ALDH1A1 | |
| SCHEMBL1747924 | 0.69 | ALDH1A1 (0.43) | L3MBTL1ALDH1A1CYP3A4CYP2C9PKM | |
| SCHEMBL1748194 | 0.68 | MMP8 (0.44) | SLC6A3L3MBTL1 | |
| SCHEMBL4220123 | 0.68 | KMT2A (0.47) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL1747956 | 0.67 | CYP2C19 (0.41) | L3MBTL1ALDH1A1CYP3A4CYP2C9PKM | |
| SCHEMBL3904681 | 0.67 | HDAC1 (0.52) | ALDH1A1CYP3A4CYP2C9PKMCYP2C19 | |
| SCHEMBL2028459 | 0.66 | CYP4F2 (0.43) | L3MBTL1ALDH1A1CYP3A4CYP2C9PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090215780-A1 | Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity | BAYER PHARMACEUTICALS CORPORATION (US) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215780-A1 | Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity | FABP4, GPR119, LIPC | SLC6A3 1440/4885SLC6A4 2156/4885P2RX7 906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.